Molok, Nezyl .
HRN: 23-40-96 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2023
CEFUROXIME 500MG (TAB)
07/28/2023
08/03/2023
PO
500mg
BID
UTI
Waiting Final Action